drugset / Trial / NCT00191906

Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD)

NCT00191906

Phase 4 Completed 121 enrolled Eli Lilly and Company
RandomizedCrossoverQuadruple-blindTreatment

Summary

To test the hypothesis that a 4 week treatment with atomoxetine is more effective than placebo in patients with combined type Attention Deficit/Hyperactivity Disorder (ADHD), patients with only Reading Disorder, and patients with combined type ADHD and Reading Disorder.

Timeline

Start
2005-04
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Atomoxetine Other / unclassified 1.2 mg/kg Oral